VALLERY ADA: Open Payments
NPI 1194430579 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 15 payments from 5 companies in 2025. Trend: 2023 $302 · 2024 $159 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $279 |
| Amgen Inc. | 3 | $155 |
| Boston Scientific Corporation | 3 | $69 |
| PFIZER INC. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
Products named: Ozempic, OTEZLA, General - Pain Management, Rybelsus, PAXLOVID, MOUNJARO, Wegovy, REPATHA.
Industry payments across TX — which companies pay providers there.
